Kala-Azar, also known as Black Fever, is a serious disease caused by a parasite called Leishmania donovani. It's spread through the bite of tiny sandflies. People who get Kala-Azar often feel very sick with high fevers, chills, and stomach problems. It can also cause the liver and spleen to swell and make the skin look greyish.
Every report comes from a Lived member, sent anonymously.
Have you tried Amphotericin B for Kala-Azar?
Kala-azar, also called visceral leishmaniasis or black fever, is a parasitic infection spread by the bite of infected sand flies. Unlike the more common skin form of leishmaniasis, it attacks internal organs, particularly the spleen, liver and bone marrow. That is why its main signs are long-lasting or recurring fever, weight loss, a swollen spleen and liver, and low blood counts. It is the most serious form of leishmaniasis: without treatment, nearly everyone with the full disease dies. With prompt and complete treatment, it is curable for most people. Most cases occur in Brazil, east Africa and South Asia. In the United States it is seen mainly in people who have lived in, travelled to or been deployed to an area where the parasite circulates.
The cause is a Leishmania parasite, a single-celled organism carried by tiny female sand flies. The flies are small and silent, so bites often go unnoticed, and they bite mostly between dusk and dawn. Dozens of animal species, as well as people, can carry the parasite. Much less often, the infection passes from mother to baby during pregnancy, or through blood transfusion, organ transplant or shared needles. Only a small share of infected people go on to develop illness. The chance rises with malnutrition and with a weakened immune system, such as from HIV or medicines that suppress immunity. In affected regions, poverty, crowded or poor housing, sleeping outdoors and large movements of people into areas of high transmission all raise risk. There is no vaccine and no medicine to prevent infection. For travelers, prevention means avoiding sand fly bites: limiting outdoor activity from dusk to dawn, wearing long sleeves and long pants, using insect repellent on exposed skin and sleeping under insecticide-treated bed nets.
Kala-azar is easy to miss outside the regions where it is common, so the first step is a clinician connecting the symptoms with where a person has lived or travelled. Symptoms usually begin weeks to months after exposure, but the infection can stay silent for years or even decades and surface later if the immune system becomes weakened. A travel history from long ago still counts. Routine blood tests often point toward it: low red cells (anemia), low white cells and low platelets, along with a high level of protein in the blood driven by antibodies and a low level of albumin. An exam usually finds an enlarged spleen, often with an enlarged liver. The diagnosis is confirmed by finding the parasite or its genetic material in a sample of blood, bone marrow, liver or lymph node tissue. Antibody tests, including rapid tests used in endemic areas, give supporting evidence but are not the whole answer on their own. In the United States, the Centers for Disease Control and Prevention (CDC) can help clinicians with testing and with identifying the parasite species, which can affect the choice of medicine.
Everyone diagnosed with kala-azar needs prompt and complete treatment. The choice of medicine depends on the parasite species, where the infection was acquired, the person's age, pregnancy and immune status. In the United States, liposomal amphotericin B (AmBisome) is generally the treatment of choice. It is a medicine also used for serious fungal infections, packaged in tiny fat particles, and is given by IV infusion over about one to two hours. For people with a normal immune system, the approved course is a daily infusion for five days followed by single doses about two and three weeks after starting. Fever, chills and nausea during or after infusions are common, and the care team checks kidney function and blood salts during treatment. Miltefosine (Impavido) is the only pill treatment. It is taken by mouth for 28 days and is approved for kala-azar caused by the species Leishmania donovani in people 12 or older who weigh at least 30 kg (66 lb). Nausea, vomiting and diarrhea are common, so it is taken with food. It can cause serious harm to a developing baby: it is not used during pregnancy, a pregnancy test is required before starting, and anyone who could become pregnant needs effective contraception during treatment and for 5 months afterward. In other parts of the world, injected antimony medicines and other drugs or combinations are also used, depending on local guidelines and the parasite species. Treatment also includes supportive care for anemia, nutrition and any other infections. People living with HIV start or adjust antiretroviral therapy alongside treatment and may need ongoing maintenance medicine to keep the infection from returning.
Kala-azar is a serious illness, and treatment comes with close monitoring of blood counts and of the medicine's side effects. For people with a working immune system, a full course usually cures the disease, and relapse or treatment failure is rare. The medicines do not remove every parasite from the body, so the immune system has to keep the remainder in check. Follow-up visits after treatment look for signs that the infection has come back. Relapse is much more likely in people with a weakened immune system, especially those living with HIV, who also face higher death rates. In that group, effective antiretroviral therapy delays relapse and improves survival. Some people, mainly those infected in east Africa or South Asia, later develop post-kala-azar dermal leishmaniasis (PKDL). This is a rash of flat spots or bumps, usually on the face, upper arms and trunk, that typically appears six months to a year or more after apparent cure, though it can appear earlier. It needs its own assessment, partly because people with PKDL can be a source of infection for sand flies and, through them, other people.
Seek medical care promptly for a fever that keeps returning or won't go away, unexplained weight loss, or a swollen belly or fullness under the left ribs if you have ever lived in or travelled to an area where kala-azar occurs, even many years ago. Mention the travel history directly, since it may not otherwise be considered. After treatment, contact your care team if fever, weight loss or tiredness return, or if a new rash appears on the face or body. If you are taking miltefosine, or finished it within the past 5 months, contact your prescriber right away if you could be pregnant.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Kala-Azar is like, what's helped you, or ask the community a question.